Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

XChange TEC.INC (XHG) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for XChange TEC.INC (XHG) over the last 9 years, with Q3 2025 value amounting to $1.8 million.

  • XChange TEC.INC's Cash & Equivalents rose 6206.69% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 6206.69%. This contributed to the annual value of $1.5 million for FY2025, which is 3586.61% up from last year.
  • Latest data reveals that XChange TEC.INC reported Cash & Equivalents of $1.8 million as of Q3 2025, which was up 6206.69% from $674000.0 recorded in Q1 2025.
  • Over the past 5 years, XChange TEC.INC's Cash & Equivalents peaked at $4.9 million during Q1 2021, and registered a low of $82311.1 during Q3 2022.
  • Over the past 5 years, XChange TEC.INC's median Cash & Equivalents value was $1.1 million (recorded in 2024), while the average stood at $1.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9673.67% in 2022, then surged by 38338.56% in 2023.
  • XChange TEC.INC's Cash & Equivalents (Quarter) stood at $2.5 million in 2021, then plummeted by 96.74% to $82311.1 in 2022, then surged by 383.39% to $397880.0 in 2023, then surged by 183.53% to $1.1 million in 2024, then soared by 62.07% to $1.8 million in 2025.
  • Its Cash & Equivalents stands at $1.8 million for Q3 2025, versus $674000.0 for Q1 2025 and $1.1 million for Q3 2024.